Initial Experience of Clinical Pharmacology and Clinical Pharmacy Interactions in a Clinical Pharmacokinetics Consultation Service
1979; Wiley; Volume: 19; Issue: 1 Linguagem: Inglês
10.1002/j.1552-4604.1979.tb01610.x
ISSN1552-4604
AutoresJerry W. Taylor, Allan J. McLean, R. G. Leonard, Thomas M. Ludden, Unamarie Clibon, B. PATRICK DU SOUICH, Steven C. Harris, David Lalka, Robert L. Talbert, N Vicuna, Charles A. Walton, J. L. McNay,
Tópico(s)Pharmaceutical Practices and Patient Outcomes
ResumoThe Journal of Clinical PharmacologyVolume 19, Issue 1 p. 1-7 Initial Experience of Clinical Pharmacology and Clinical Pharmacy Interactions in a Clinical Pharmacokinetics Consultation Service JERRY W. TAYLOR Pharm.D., JERRY W. TAYLOR Pharm.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorDr. ALLAN J. McLEAN M.D., Ph.D., F.R.A.C.P., Corresponding Author Dr. ALLAN J. McLEAN M.D., Ph.D., F.R.A.C.P. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Clinical Research Unit, Alfred Hospital, Commercial Road, Prahran 3181, Melbourne, Victoria, Australia.Search for more papers by this authorROBERT G. LEONARD Pharm. D., ROBERT G. LEONARD Pharm. D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorTHOMAS M. LUDDEN Ph.D., THOMAS M. LUDDEN Ph.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorUNAMARIE CLIBON Pharm.D., UNAMARIE CLIBON Pharm.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorB. PATRICK DU SOUICH M.D., B. PATRICK DU SOUICH M.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorSTEVEN C. HARRIS M.D., STEVEN C. HARRIS M.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorDAVID LALKA Ph.D., DAVID LALKA Ph.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorROBERT L. TALBERT Pharm.D., ROBERT L. TALBERT Pharm.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorNELSON VICUNA M.D., NELSON VICUNA M.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorCHARLES A. WALTON Ph.D., CHARLES A. WALTON Ph.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorJOHN L. McNAY M.D., JOHN L. McNAY M.D. Division of Clinical Pharmacology and Hypertension, Departments of Medicine, Pharmacology and Pathology, University of Texas Health Science Center at San Antonio, Tex. 78284.Search for more papers by this author JERRY W. TAYLOR Pharm.D., JERRY W. TAYLOR Pharm.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorDr. ALLAN J. McLEAN M.D., Ph.D., F.R.A.C.P., Corresponding Author Dr. ALLAN J. McLEAN M.D., Ph.D., F.R.A.C.P. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Clinical Research Unit, Alfred Hospital, Commercial Road, Prahran 3181, Melbourne, Victoria, Australia.Search for more papers by this authorROBERT G. LEONARD Pharm. D., ROBERT G. LEONARD Pharm. D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorTHOMAS M. LUDDEN Ph.D., THOMAS M. LUDDEN Ph.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorUNAMARIE CLIBON Pharm.D., UNAMARIE CLIBON Pharm.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorB. PATRICK DU SOUICH M.D., B. PATRICK DU SOUICH M.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorSTEVEN C. HARRIS M.D., STEVEN C. HARRIS M.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorDAVID LALKA Ph.D., DAVID LALKA Ph.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorROBERT L. TALBERT Pharm.D., ROBERT L. TALBERT Pharm.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorNELSON VICUNA M.D., NELSON VICUNA M.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorCHARLES A. WALTON Ph.D., CHARLES A. WALTON Ph.D. Clinical Pharmacy Program at San Antonio, University of Texas College of Pharmacy at Austin, Tex.Search for more papers by this authorJOHN L. McNAY M.D., JOHN L. McNAY M.D. Division of Clinical Pharmacology and Hypertension, Departments of Medicine, Pharmacology and Pathology, University of Texas Health Science Center at San Antonio, Tex. 78284.Search for more papers by this author First published: January 1979 https://doi.org/10.1002/j.1552-4604.1979.tb01610.xCitations: 15AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Lasagna, L.: Clinical pharmacology: present status and future development. Science 152: 388 (1966). 10.1126/science.152.3720.388 CASPubMedWeb of Science®Google Scholar 2 Pellegrino, E. D.: The role of the pharmacist in rational therapeutics. Hospitals 37: 102 (1963). Google Scholar 3 Ebert, R. H.: Changes in the health system. J. Amer. Pharm. Assoc. N89: 402 (1969). Google Scholar 4 Walton, C. A.: Clinical pharmacy practice and education—the concept and its implementation. Amer. J. Pharm. 141: 186 (1969). Web of Science®Google Scholar 5 Francke, D. E.: Relationship between clinical pharmacology and clinical pharmacy. J. Clin. Pharmacol. 12: 384 (1972). 10.1002/j.1552-4604.1972.tb00134.x CASPubMedWeb of Science®Google Scholar 6 Walton, C. A.: Clinical pharmacology and clinical pharmacy: a necessary alliance for practical advances in rational drug therapy. J. Clin. Pharmacol. 14: 1 (1974). 10.1002/j.1552-4604.1974.tb02279.x CASPubMedWeb of Science®Google Scholar 7 Gibaldi, M.: The clinical pharmacokinetics laboratory of the School of Pharmacy State University of New York at Buffalo. In Clinical Pharmacokinetics. A Symposium, G. Levy, Ed. Washington, D.C., American Pharmaceutical Association (Academy of Pharmaceutical Sciences, 1974, p. 11. Web of Science®Google Scholar 8 Walton, C.: Views of a pharmacy educator. In Clinical Pharmacy and Clinical Pharmacology, W. A. Gouveia, G. Tognoni, and E. Kleijn, Eds. Amsterdam, Elsevier/North Holland Biomedical Press, 1976, p. 427. Google Scholar 9 Burkholder, D.: Operation of the drug information service at the University of Kentucky Medical Center. Amer. J. Hosp. Pharm. 22: 48 (1965). Google Scholar 10 Francke, D. E.: The role of the pharmacist as a drug information specialist. Amer. J. Hosp. Pharm. 28: 49 (1966). Google Scholar 11 Munzenberger, P. J., Swanson, L. N., Smith, R. E., Zalewski, F. H., Schwartz, J. I., and Billingsley, L. A.: A cost/impact analysis of selected clinical pharmacy functions in three hospitals. Amer. J. Hosp. Pharm, 31: 947 (1974). CASPubMedWeb of Science®Google Scholar 12 Keys, P. W., South, J. C., and Duffy, M. G.: Quality of care evaluation applied to assessment of clinical pharmacy services. Amer. J. Hosp. Pharm. 32: 897 (1975). CASPubMedWeb of Science®Google Scholar 13 Puckett, W. H., and Visconti, J. A.: An epidemiological study of the clinical significancy of drug—drug interactions in a private community hospital. Amer. J. Hosp. Pharm. 28: 247 (1971). PubMedWeb of Science®Google Scholar 14 Ellinoy, B. J., Mays, J. F., McSherry, P. V., and Rosenthal, L. C.: A pharmacy outpatient monitoring program providing primary medical care to selected patients. Amer. J. Hosp. Pharm. 30: 593 (1973). CASPubMedWeb of Science®Google Scholar 15 Mattel, T. J., Balmer, J. A., Corbin, L. A., and Duffy, M. G.: Hypertension: a model for pharmacy involvement. Amer. J. Hosp. Pharm. 30: 683 (1973). Google Scholar 16 Koch-Weser, J.: The serum level approach to individualization of drug dosage. Europ. J. Clin. Pharmacol. 9: 1 (1975). 10.1007/BF00613423 CASPubMedWeb of Science®Google Scholar 17 Gibaldi, M.: Plasma drug concentrations as therapeutic guides. In Biopharmaceutics and Clinical Pharmacokinetics.Philadelphia, Lea and Febiger, 1977, p. 153. Google Scholar 18 Jelliffe, R. W., and Brooker, G.: A nomogram for digoxin therapy. Amer. J. Med. 57: 63 (1974). 10.1016/0002-9343(74)90769-4 CASPubMedWeb of Science®Google Scholar 19 Koup, J. R., Jusko, W. J., Elwood, C. M., and Kohli, R. K.: Digoxin pharmacokinetics: role of renal failure in dosage regimen design. Clin. Pharmacol. Therap. 18: 9 (1976). Web of Science®Google Scholar 20 Ludden, T. H., Allen, J. P., Valutsky, W. A., Vicuna, A. V., Nappi, J. M., Hoffman, S., Wallace, J. E., Lalka, D., and McNay, J. L.: Individualization of phenytoin dosage regimens. Clin. Pharmacol. Therap. 21: 287 (1977). 10.1002/cpt1977213287 CASPubMedWeb of Science®Google Scholar 21 Mawer, G. E., Mullen, P. W., Rodgers, M., Robins, A. J., and Lucas, S. B.: Phenytoin dose adjustment in epileptic patients, Brit. J. Clin. Pharmacol. 1: 163 (1974). 10.1111/j.1365-2125.1974.tb00226.x CASPubMedWeb of Science®Google Scholar 22 Wilson, J. T., and Wilkinson, G. R.: Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses. Neurology 24: 614 (1974). 10.1212/WNL.24.7.614 CASPubMedWeb of Science®Google Scholar 23 Anderson, A. C., Hodges, G. R., and Barnes, W. G.: Determination of serum amicin sulfate levels. Ordering patterns and use as a guide to therapy. Arch, Int. Med. 136: 785 (1976). 10.1001/archinte.1976.03630070033010 CASPubMedWeb of Science®Google Scholar 24 Levy, G.: A training program in Clinical Pharmacokinetics. Drug Intell. Clin. Pharm. 12: 204 (1978). 10.1177/106002807801200401 Web of Science®Google Scholar Citing Literature Volume19, Issue1January 1979Pages 1-7 ReferencesRelatedInformation
Referência(s)